Analyze the major players and growth drivers in the US appendix cancer drugs market, including targeted therapies from copyright, immunotherapy combos, and repurposed oncology drugs improving therapeutic options. https://www.openpr.com/news/4318370/united-states-appendix-cancer-drugs-market-advances-as-targeted